8 results on '"Yu, Xi‐Yong"'
Search Results
2. Generation of Functional Human Cardiac Progenitor Cells by High-Efficiency Protein Transduction.
- Author
-
Li XH, Li Q, Jiang L, Deng C, Liu Z, Fu Y, Zhang M, Tan H, Feng Y, Shan Z, Wang J, and Yu XY
- Subjects
- Animals, Cytokines pharmacology, Fibroblasts cytology, Humans, Rats, Transcription Factors metabolism, Transduction, Genetic, Cell Differentiation, Cellular Reprogramming Techniques, Fibroblasts metabolism, Induced Pluripotent Stem Cells cytology, Induced Pluripotent Stem Cells metabolism, Induced Pluripotent Stem Cells transplantation, Myocardial Infarction metabolism, Myocardial Infarction therapy, Myocytes, Cardiac cytology, Myocytes, Cardiac metabolism, Myocytes, Cardiac transplantation
- Abstract
Unlabelled: The reprogramming of fibroblasts to induced pluripotent stem cells raises the possibility that somatic cells could be directly reprogrammed to cardiac progenitor cells (CPCs). The present study aimed to assess highly efficient protein-based approaches to reduce or eliminate the genetic manipulations to generate CPCs for cardiac regeneration therapy. A combination of QQ-reagent-modified Gata4, Hand2, Mef2c, and Tbx5 and three cytokines rapidly and efficiently reprogrammed human dermal fibroblasts (HDFs) into CPCs. This reprogramming process enriched trimethylated histone H3 lysine 4, monoacetylated histone H3 lysine 9, and Baf60c at the Nkx2.5 cardiac enhancer region by the chromatin immunoprecipitation quantitative polymerase chain reaction assay. Protein-induced CPCs transplanted into rat hearts after myocardial infarction improved cardiac function, and this was related to differentiation into cardiomyocyte-like cells. These findings demonstrate that the highly efficient protein-transduction method can directly reprogram HDFs into CPCs. This protein reprogramming strategy lays the foundation for future refinements both in vitro and in vivo and might provide a source of CPCs for regenerative approaches., Significance: The findings from the present study have demonstrated an efficient protein-transduction method of directly reprogramming fibroblasts into cardiac progenitor cells. These results have great potential in cell-based therapy for cardiovascular diseases., (©AlphaMed Press.)
- Published
- 2015
- Full Text
- View/download PDF
3. Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR/Cas9-based transcriptional activators.
- Author
-
Wang, Jianglin, Jiang, Xueyan, Zhao, Lixin, Zuo, Shengjia, Chen, Xiantong, Zhang, Lingmin, Lin, Zhongxiao, Zhao, Xiaoya, Qin, Yuyan, Zhou, Xinke, and Yu, Xi-Yong
- Subjects
HEART cells ,PROGENITOR cells ,MUSCLE cells ,GENETIC regulation ,FIBROBLASTS - Abstract
Overexpression of exogenous lineage-determining factors succeeds in directly reprogramming fibroblasts to various cell types. Several studies have reported reprogramming of fibroblasts into induced cardiac progenitor cells (iCPCs). CRISPR/Cas9-mediated gene activation is a potential approach for cellular reprogramming due to its high precision and multiplexing capacity. Here we show lineage reprogramming to iCPCs through a dead Cas9 (dCas9)-based transcription activation system. Targeted and robust activation of endogenous cardiac factors, including GATA4, HAND2, MEF2C and TBX5 (G, H, M and T; GHMT), can reprogram human fibroblasts toward iCPCs. The iCPCs show potentials to differentiate into cardiomyocytes, smooth muscle cells and endothelial cells in vitro. Addition of MEIS1 to GHMT induces cell cycle arrest in G2/M and facilitates cardiac reprogramming. Lineage reprogramming of human fibroblasts into iCPCs provides a promising cellular resource for disease modeling, drug discovery and individualized cardiac cell therapy. Human foreskin fibroblasts were reprogrammed into induced cardiac progenitor cells via a CRISPR/Cas9-based synergistic activation mediator-mediated gene activation. Image 1 [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair.
- Author
-
Shao, Lianbo, Zhang, Yu, Lan, Beibei, Wang, Juanjuan, Zhang, Zhiwei, Zhang, Lulu, Xiao, Pengli, Meng, Qingyou, Geng, Yong-jian, Yu, Xi-yong, and Li, Yangxin
- Subjects
HEART physiology ,MYOCARDIAL infarction treatment ,INFLAMMATION prevention ,FIBROSIS ,RNA analysis ,ANIMAL experimentation ,ANTIGENS ,APOPTOSIS ,BIOLOGICAL models ,CELL culture ,CELL physiology ,CELLULAR therapy ,CHI-squared test ,COMPARATIVE studies ,FIBROBLASTS ,FISHER exact test ,FLOW cytometry ,HEART cells ,MYOCARDIUM ,PROBABILITY theory ,RATS ,RESEARCH funding ,RNA ,STATISTICS ,STEM cells ,WESTERN immunoblotting ,DATA analysis ,DATA analysis software ,EXOSOMES ,DESCRIPTIVE statistics ,SEQUENCE analysis ,IN vitro studies ,MANN Whitney U Test ,KRUSKAL-Wallis Test ,PREVENTION - Abstract
Mesenchymal stem cells (MSCs) repair infarcted heart through paracrine mechanism. We sought to compare the effectiveness of MSCs and MSC-derived exosomes (MSC-Exo) in repairing infarcted hearts and to identify how MSC-Exo mediated cardiac repair is regulated. In a rat myocardial infarction model, we found that MSC-Exo inhibited cardiac fibrosis, inflammation, and improved cardiac function. The beneficial effects of MSC-Exo were significantly superior compared to that of MSCs. To explore the potential mechanisms underlying MSC-Exo’s effects, we performed several in vitro experiments and miRNA-sequence analysis. MSC-Exo stimulated cardiomyocyte H9C2 cell proliferation, inhibited apoptosis induced by H
2 O2 , and inhibited TGF-β induced transformation of fibroblast cell into myofibroblast. Importantly, novel miRNA sequencing results indicated that MSC-Exo and MSCs have similar miRNA expression profile, which could be one of the reasons that MSC-Exo can replace MSCs for cardiac repair. In addition, the expression of several miRNAs from MSC-Exo was significantly different from that of MSCs, which may explain why MSC-Exo has better therapeutic effect than MSCs. In conclusion, this study demonstrates that MSC-Exo could be used alone to promote cardiac repair and are superior to MSCs in repairing injured myocardium. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
5. Fn14 Promotes Differentiation of Human Mesenchymal Stem Cells into Heart Valvular Interstitial Cells by Phenotypic Characterization.
- Author
-
Huang, Wei, Xiao, Ding‐Zhang, Wang, Yigang, Shan, Zhi‐Xin, Liu, Xiao‐Ying, Lin, Qiu‐Xiong, Yang, Min, Zhuang, Jian, Li, Yangxin, and Yu, Xi‐Yong
- Subjects
MESENCHYMAL stem cell differentiation ,HEART valve diseases ,INTERSTITIAL cells ,PHENOTYPES ,FIBROBLASTS ,HEART cells ,EXTRACELLULAR matrix ,THERAPEUTICS - Abstract
Despite the fact that tissue engineered heart valves (TEHV) hold great promise for heart valve disease treatment, one of the challenges is to find suitable seeding cells. Bone marrow derived mesenchymal stem cells (MSCs) were considered to be one of the best seed cell sources. In this study we propose a novel approach to promote stem cell differentiation into the seed cells of TEHV, valvular interstitial cells (VICs). Newly induced MSCs (iMSCs) were created from a co-culture niche in which healthy human donor derived MSCs were co-cultured with cardiac fibroblasts (H9C2 cell line). Then iMSCs were transfected with either a mock vector (iMSCs
mock ) as controls or with a vector that overexpresses thefibroblast inducible factor 14 (Fn14) gene (iMSCsFn14 ). Immunofluorescence staining was performed to assay VIC differentiation. Western blot analysis was performed to analyze the involved signaling pathway. The results demonstrate that the expression of α-smooth muscle actin (SMA) was significantly higher in iMSCsFn14 as compared with iMSCmock , and MSC, and also had higher co-alignment of α-actinin and stress fiber (F-actin) in bundles. Additionally, increased biosynthesis of extracellular matrix (ECM) proteins including collagen I, collagen III, and fibronection were observed in iMSCsFn14 in comparison with iMSCsmock . These data observed in iMSCsFn14 were in accordance with VIC phenotype from normal heart valves. In addition, the PI3K/Akt signaling pathway was activated in iMSCsFn14 which allowed higher Akt phosphorylation (p-Akt) levels and SMA levels, whereas, it was attenuated by LY294002 (PI3K/Akt inhibitor). These new findings of the effect of Fn14 on VIC-like cell differentiation may provide a novel therapeutic strategy for heart valve disease treatment. J. Cell. Physiol. 229: 580-587, 2014. © 2013 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
6. Molecular Strategy to Reduce In Vivo Collagen Barrier Promotes Entry of NCX1 Positive Inducible Pluripotent Stem Cells (iPSCNCX1+) into Ischemic (or Injured) Myocardium.
- Author
-
Huang, Wei, Dai, Bo, Wen, Zhili, Millard, Ronald W., Yu, Xi-Yong, Luther, Kristin, Xu, Meifeng, Zhao, Ting C., Yang, Huang-Tian, Qi, Zhihua, LaSance, Kathleen, Ashraf, Muhammad, and Wang, Yigang
- Subjects
MYOCARDIAL infarction ,ISCHEMIA ,PLURIPOTENT stem cells ,MOLECULAR biology ,COLLAGEN ,PROGENITOR cells ,FIBROBLASTS ,DEVELOPMENTAL cytology ,LABORATORY mice - Abstract
Objective: The purpose of this study was to assess the effect of collagen composition on engraftment of progenitor cells within infarcted myocardium. Background: We previously reported that intramyocardial penetration of stem/progenitor cells in epicardial patches was enhanced when collagen was reduced in hearts overexpressing adenylyl cyclase-6 (AC6). In this study we hypothesized an alternative strategy wherein overexpression of microRNA-29b (miR-29b), inhibiting mRNAs that encode cardiac fibroblast proteins involved in fibrosis, would similarly facilitate progenitor cell migration into infarcted rat myocardium. Methods: In vitro: A tri-cell patch (Tri-P) consisting of cardiac sodium-calcium exchanger-1 (NCX1) positive iPSC (iPSC
NCX1+ ), endothelial cells (EC), and mouse embryonic fibroblasts (MEF) was created, co-cultured, and seeded on isolated peritoneum. The expression of fibrosis-related genes was analyzed in cardiac fibroblasts (CFb) by qPCR and Western blot. In vivo: Nude rat hearts were administered mimic miRNA-29b (miR-29b), miRNA-29b inhibitor (Anti-29b), or negative mimic (Ctrl) before creation of an ischemically induced regional myocardial infarction (MI). The Tri-P was placed over the infarcted region 7 days later. Angiomyogenesis was analyzed by micro-CT imaging and immunofluorescent staining. Echocardiography was performed weekly. Results: The number of green fluorescent protein positive (GFP+ ) cells, capillary density, and heart function were significantly increased in hearts overexpressing miR-29b as compared with Ctrl and Anti-29b groups. Conversely, down-regulation of miR-29b with anti-29b in vitro and in vivo induced interstitial fibrosis and cardiac remodeling. Conclusion: Overexpression of miR-29b significantly reduced scar formation after MI and facilitated iPSCNCX1+ penetration from the cell patch into the infarcted area, resulting in restoration of heart function after MI. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
7. Letter by Li et al Regarding Article, "MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis".
- Author
-
Yangxin Li, Yao-Hua Song, Xi-Yong Yu, Nagpal, Varun, Rai, Rahul, Place, Aaron T., Murphy, Sheila B., Verma, Suresh K., Ghosh, Asish K., Vaughan, Douglas E., Li, Yangxin, Song, Yao-Hua, and Yu, Xi-Yong
- Subjects
- *
FIBROBLASTS , *MYOFIBROBLASTS , *HEART fibrosis , *COMPARATIVE studies , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *RNA , *EVALUATION research - Abstract
A letter to the editor is presented in response to the article "MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis" by S. K. Verma and others in the 2016 issue along with the authors' response to the same.
- Published
- 2016
- Full Text
- View/download PDF
8. GW26-e2263 Protein Reprogramming Fibroblasts Into Cardiac Progenitor Cells for Cardiac Repair.
- Author
-
Li, Xiaohong, Jiang, Lin, Fu, Yongheng, Zhang, Mengzhen, Tan, Honghong, Deng, Chunyu, Shan, Zhixin, Geng, Qingshan, Wang, Jianjun, and Yu, Xi-yong
- Subjects
- *
FIBROBLASTS , *HEART cells , *PROGENITOR cells , *CARDIAC regeneration , *HEART diseases , *THERAPEUTICS , *CELL differentiation , *PROTEIN expression - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.